Nov 17 2014
Attorney General’s Office presents argument defending rules requiring pharmacies to fill lawful prescriptions
PORTLAND, Ore. — This week, the Attorney General’s Office will defend rules requiring pharmacies to fill lawful prescriptions for time-sensitive medications.
May 20 2013
OLYMPIA—Washington has joined with other states and the federal government in a $500 million dollar settlement to resolve civil and criminal allegations against Ranbaxy, a generic pharmaceutical manufacturer based in Gurgaon, India. The company is alleged to have introduced adulterated—or tainted— drugs into interstate commerce, resulting in false or fraudulent claims being submitted to Washington’s Medicaid Program.
May 2 2013
Drug Manufacturer Amgen Agrees To Pay Medicaid Program Nearly $26 Million To Resolve Two False Claims Cases
Attorney General Bob Ferguson announced today Washington has joined a national settlement against the drug manufacturer Amgen, Inc., resolving allegations that Amgen violated certain state false claims acts by reporting inflated pricing data for its prescription drugs Aranesp, Enbrel, Epogen, Neulasta, Neupogen, and Sensipar.
Dec 19 2012
OLYMPIA – Washington State Attorney General Rob McKenna today announced that Washington joined with other states and the federal government to reach an agreement with Amgen, Inc., settling allegations that the drug-maker illegally marketed several drugs.
Dec 12 2012
State attorneys general reach deal over Zyvox and Lyrica SEATTLE – Washington State Attorney General Rob McKenna today announced that he and 33 other state attorneys general reached a $42.9 million settlement with Pfizer Inc. to resolve allegations that the company unlawfully promoted its drugs, Zyvox and Lyrica.
Aug 30 2012
SEATTLE – Washington State Attorney General Rob McKenna today announced that he and 36 other Attorneys General reached a record $181 million dollar settlement with Janssen Pharmaceuticals, Inc., a subsidiary of Johnson and Johnson. McKenna and his colleagues allege that Janssen improperly marketed the antipsychotic drugs Risperdal, Risperdal Consta, Risperdal M-Tab and Invega.
Jul 3 2012
GlaxoSmithKline settles drug marketing and pricing claims OLYMPIA –Attorney General Rob McKenna today announced Washington state’s share of the largest healthcare fraud settlement in U.S. history.
May 14 2012
GRAND MOUND, Wash.—A group of young Southeast Asian American students shared their experiences as members of a Seattle film project and walked away with the Grand Prize at the 2012 Spring Youth Forum-- a $3,000 partial scholarship to an upcoming prevention leadership conference.
May 7 2012
Settlements involving consumer protection, Medicaid claims over illegal marketing of DepakoteSEATTLE – Working with other states, attorneys for the Washington State Attorney General’s Office have recovered more than $12 million through settlements with Illinois-based Abbott Laboratories, accused of illegally marketing an anti-seizure drug. The state will recover more than $10 million, split with the federal government, in a multi-state Medicaid fraud case against the company and more than $2 million from a consumer protection case.
Jul 5 2011
Families in foreclosure, mental health patients among those to benefit from Attorney General’s settlements
SEATTLE – Programs to help Washington homeowners avoid foreclosure and improve the lives of mental health patients and those suffering from gastrointestinal diseases were recently awarded grants by the Attorney General’s Office.